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Abstract
Background: Many biological repositories store information based on experimental study of the
biological processes within a cell, such as protein-protein interactions, metabolic pathways, signal
transduction pathways, or regulations of transcription factors and miRNA. Unfortunately, it is
difficult to directly use such information when generating simulation-based models. Thus, modeling
rules for encoding biological knowledge into system-dynamics-oriented standardized formats
would be very useful for fully understanding cellular dynamics at the system level.
Results:  We selected the TRANSPATH database, a manually curated high-quality pathway
database, which provides a plentiful source of cellular events in humans, mice, and rats, collected
from over 31,500 publications. In this work, we have developed 16 modeling rules based on hybrid
functional Petri net with extension (HFPNe), which is suitable for graphical representing and
simulating biological processes. In the modeling rules, each Petri net element is incorporated with
Cell System Ontology to enable semantic interoperability of models. As a formal ontology for
biological pathway modeling with dynamics, CSO also defines biological terminology and
corresponding icons. By combining HFPNe with the CSO features, it is possible to make
TRANSPATH data to simulation-based and semantically valid models. The results are encoded into
a biological pathway format, Cell System Markup Language (CSML), which eases the exchange and
integration of biological data and models.
Conclusion: By using the 16 modeling rules, 97% of the reactions in TRANSPATH are converted
into simulation-based models represented in CSML. This reconstruction demonstrates that it is
possible to use our rules to generate quantitative models from static pathway descriptions.
Background
Biological pathways are reaction-networks of the biologi-
cal processes within a cell, which can be classified into
three categories: gene regulatory networks, metabolic
pathways and signaling pathways. Due to the nature of
concurrency of biological pathways, Petri nets have been
used to model and analyze biological pathways in many
studies [1-9].
Nagasaki et al. [10] have proposed an object-oriented Petri
nets called hybrid functional Petri net with extension
(HFPNe) for modeling complex biological systems.
HFPNe-based modeling allows users to easily understand
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biological networks with a graphical representation and
reveals the expressiveness when representing the dynamic
behaviors of sophisticated biological pathways. To
improve the maintainability and reusability of HFPNe
models, we have developed an XML format called the Cell
System Markup Language (CSML) [11], with the aim of
creating an exchange format for modeling, visualizing,
and simulating biological pathways.
Information about biological networks has been accumu-
lated over many years, mainly through experimental anal-
yses. However, there is a growing need for a framework to
interpret biological data in an integrated manner and, fur-
ther, to simulate and predict biological functions beyond
simply storing and querying data. It is essential for such a
framework to have incorporated the capability to visually
represent system dynamics. There are several works to
convert biological pathways into Petri net representation
[12-15]. However the results are not saved into an
exchange format. Although there are several formats to
represent biological pathways, such as SBML [16], CellML
[17], and BioPAX [18], these formats do not fully support
both visualization and simulation of biological pathways.
Instead, various tools have been developed to perform
these functions independently. However, visualization
tools generate images, mostly displayed as static pictures,
and save them in noneditable binary files. Simulation
tools usually encode model parameters into the program-
ming language. Hence, it is not easy to change those
parameters or to integrate them with other resources.
In this paper, we present a method for increasing the over-
all utilization of the valuable pathway data available in
conventional pathway databases.
Hybrid functional Petri net with extension
CSML is based on HFPNe, a graphical language, for mod-
eling and simulation of biological pathways. Thus, we
first describe the basic elements of HFPNe and then how
these elements are modeled in CSML. The formal defini-
tion of HFPNe is provided in Nagasaki et al. [10].
• HFPNe consists of two types of nodes, called entities and
processes, and three types of connectors – the formal
terms in Petri nets are places, transitions, and arcs, respec-
tively. Renaming the elements would make them more
intuitive and easier for biologists to understand.
￿ Entities, represented by circles as a visual component,
model biological objects (e.g., mRNAs, proteins, and
chemical compounds), conditions (e.g., pH and tempera-
ture), states (e.g., the on/off state of a genetic switch), and
cellular organelles (e.g., nucleus and cytoplasm). In the
case of chemical reactions, the compounds involved usu-
ally have specific quantities. In HFPNe, an entity can take
any object that can be represented in programming lan-
guages like an instance of a class in C++ or Java. In a sim-
ple model, an object may take a primitive value such as a
positive integer for the copy number of an mRNA and a
real value for the concentration of a protein.
￿ Processes, represented by boxes as a visual component,
model events among entities, such as phosphorylation,
translocation, and apoptosis. In HFPNe, each process can
define any event/function that can be performed by pro-
gramming languages. In a simple model, the event/func-
tion can be the speed of a reaction or a discrete reaction.
￿ Connectors always connect an entity with a process via
a directed edge and describe the relationship between
nodes. HFPNe defines three different types of connectors
– a process connector, an association connector, and an
inhibitory connector – represented by a solid line, a
dashed line, and a solid line with a rectangle head as a vis-
ual component, respectively. The process connector can
be used both as an input and output connector. In addi-
tion, it is possible to assign a function to each process con-
nector. Therefore, the values of entities increase or
decrease depending on the direction of the process con-
nector and the function defined in the connected process.
On the other hand, the values of entities connected with
association or inhibitory connectors are not changed. The
association connector can be used only as an input con-
nector and is used to enhance the reaction of the process,
whereas the behavior of the inhibitory connector is the
opposite. All connectors can take values or scripts as a
threshold attribute and specify the active state of the proc-
ess. The graphical notations of HFPNe components are
shown in Figure 1.
Model structure in CSML
The CSML format primarily consists of model, view, bio-
logical property, and simulation property. The structure of
CSML is as follows: The top-level element in CSML is
csml:project, which has an id and a version attribute, and
represents a pathway model. The csml:project element
contains a single csml:model element. The csml:model
element also has an id and a name attribute, and takes the
following elements: csml:entitySet, csml:processSet, and
csml:factSet; these are sets of csml:entity, csml:process,
and csml:fact, respectively. The outline of the CSML struc-
ture is shown in Table 1.
The csml:entity and csml:process elements respectively
represent an entity and a process in HFPNe. In csml:proc-
ess, the entities involved in a process are represented via
the csml:connector element, which denotes a connector
in HFPNe. The csml:connector element connects the cor-
responding process and the involved entities by referenc-
ing the ids of csml:entity. The csml:fact element representsBMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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some of the properties of the modeling pathway that can-
not be described in HFPNe. For example, the functionality
of a pathway and the status of a dynamic simulation are
useful in gaining an overall understanding of the path-
way. This kind of information is represented as csml:fact.
Each of csml:entity, csml:process, csml:fact, and csml:con-
nector has a type attribute indicating the semantic con-
straints on the meaning of each element. The type
attribute has a value that is a class name hierarchically
conceptualized in the Cell System Ontology (CSO) [19].
CSO is a formal ontology for biological pathway mode-
ling with dynamics. The basic components of HFPNe –
csml:entity, csml:process, and csml:connector – have their
own biological properties, simulation properties, and
view properties. The csml:biologicalProperty element is
associated with the core terms defined in CSO to annotate
biological properties such as cellular components and
biological events. CSO also defines controlled vocabulary
terms internal to the ontology. The csml:simulationProp-
erty element is used to represent detailed simulation rules
in HFPNe. The csml:viewProperty element comprises sev-
eral elements for the visualization of pathway compo-
nents, such as an image file, graphical shape, and
geometrical position. This property is rarely included in
other formats such as SBML[16] and CellML[17].
Additionally, in CSML, it is possible to create sub-models
from the main model by using filtering and selection. For
such sub-models, multiple views can be assigned. How-
ever, these features are not used in this work.
TRANSPATH
The TRANSPATH database [20] is designed to provide
information about the intracellular signaling pathways.
The database presents such information on different
abstraction levels of the reactions with all the required
molecular information about post-modification processes
and complexes. TRANSPATH offers molecular details of
the signal flow from the cell surface into the nucleus,
focusing on mammals such as humans, mice, and rats.
The database contains information manually extracted
from the literature, except for the 1,129 initial molecules
imported from SWISS-PROT release 36. As of April 2007,
TRANSPATH Professional release 8.1 contains about
74,000 molecules, over 25,500 genes and over 115,000
reactions collected from approximately 31,500 references
[21]. In addition, each reaction is provided with a reliabil-
Graphical notations of HFPNe components Figure 1
Graphical notations of HFPNe components. Redrawn from Nagasaki et al. [10] (Figure 1).
generic process generic entity
associate connector
discrete entity 
continuous entity
inhibitory connector
process connector
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ity value based on the quality of experimental data in the
primary literature. In terms of both the quantity and qual-
ity of data collected, TRANSPATH is considered to be very
valuable to researches in biochemistry and molecular
biology.
Summary
Modeling, visualizing, and simulating biological path-
ways are becoming increasingly important tasks for
understanding dynamic cell systems. We have been devel-
oped an XML language, CSML, as an integrated frame-
work for such tasks. This work provides a methodology for
reconstructing information from the TRANSPATH data-
base into the CSML format, one based upon the HFPNe
modeling rules. A major challenge is to accurately trans-
late the information from a pathway database to an
exchange format that enables dynamic simulation with
visualization. The CSML and its platforms [22-25] could
be used to check whether the model is represented in a
consistent way, it is amenable to quantitative simulation,
and the pathway components are correctly located in cel-
lular location. The individual reactions and combinations
of reactions in TRANSPATH are evaluated by the HFPNe
modeling rules and translated into CSML. In addition, the
reconstruction could allow easy exchange and integration
of signal transduction information, which will enhance
the usability of the TRANSPATH database.
Results
The full contents of the TRANSPATH database are sup-
plied in the XML (Extensible Markup Language) format
[26]. Hereinafter, we refer to the TRANSPATH database as
TP; the term TP might be used to indicate the XML format
itself whose tags are prefixed with "tp:." Based on the
HFPNe modeling rules described in Methods section, we
have implemented the converter Transpath2CSML that
can reconstruct reactions and pathways defined in TP into
CSML. During reconstruction, entities and processes defi-
cient in TP but necessary for simulation-based models are
inferred and added to create valid CSML models.
In the following sections, we describe the reconstruction
results for the main components in TP: molecule, reac-
tion, and pathway. The HFPNe modeling rules are devel-
oped at the reaction level in TP. For molecules including
genes, we focused on the visualization.
Note that there are also elements common to the TP com-
ponents, such as tp:creator, tp:updator, tp:name, tp:syno-
nyms, and tp:comments. The tp:creator and tp:updator
elements indicate who registered and updated the data,
respectively. The tp:name and tp:synonyms elements
denote the name of the component and its synonyms. The
tp:comments element is a text-based comment for infor-
mation that cannot be described in other tags. These tags
are also mapped to the CSML format without any loss of
information, although they are not shown in this paper.
For molecules
The molecules in TP are hierarchically classified [20] such
as basic, isogroup, family for proteins. This type is not dis-
tinguished from the name of the molecule without
extracting the detail. Visualization can help interpret large
quantities of complex data. For this, we propose the visu-
alization method to fully reflect the relationship among
molecule types.
Regular polygons are used for proteins. Each nonprotein
is also depicted as an icon. Different numbers of line seg-
ments are used to distinguish families, isogroups, and
basic types, i.e., 4, 5, and 6, respectively. Different line pat-
terns of polygons are used to distinguish proteins at the
level of an orthofamily. There are, in total, 952 ortho-
family proteins in TP. Each orthofamily is assigned to a
line pattern and color, and then the proteins belonging to
the same orthofamily are assigned to similar colors during
conversion. In addition, an mRNA and its product protein
use the same color to indicate their relationship. We also
designed icons representing different species and post-
translational modification. These icons are attached to
polygons on the fly during conversion. A complex protein
is shown as composed of the graphics of its components.
The generated graphics are saved in the SVG (Scalable Vec-
Table 1: The main structure of CSML.
<csml:project>
<csml:model modelID="" modelVersionID="">
<csml:entitySet>
<csml:entity>*
</csml:entitySet>{0,1}
<csml:processSet>
<csml:process id="" name="" type="">*
<connectorList><connector/>+</connectorList>{0,1}
</csml:processSet>{0,1}
<csml:factSet>
<csml:fact>*
</csml:factSet>{0,1}
<csml:simulationProperty>{0,1}
<csml:biologicalProperty/>{0,1}
</csml:model>
<csml:subModelSet/>
<csml:globalSimulatinProperty/>
<csml:globalViewProperty/>
<csml:globalAnimationProperty/>
<csml:chartSet/>
<csml:viewSet/>
<csml:globalBiologicalProperty/>
<csml:references/>
</csml:project>
The tags explained in the context are shown in black. On the other 
hand, the grey part is not explained in the manuscript, which is mainly 
to describe the global properties for the project level.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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tor Graphics) format [27] and embedded into CSML. Cur-
rently both scalable and nonscalable image formats are
supported in CSML. Figure 2 shows the automatically gen-
erated graphics of molecules categorized into the Cdc25
family.
From the graphic of a molecule, the type of molecule is
easily identified. For example, in TP, two semantic type
reactions, XN000112679 and XN000058018, have the
same tp:name, AVO3(h) --> rictor(h), i.e., AVO3 expresses
rictor in humans. The difference between the two reac-
tions is the type of rictor, i.e., a basic type in
XN000112679 and an isogroup type in XN000058018.
Figure 3 shows the converted results for two reactions: (a)
XN000112679 and (b) XN000058018. The output entity
rictor is drawn as hexagon in (a) and pentagon in (b),
which will reduce the effort required to extract the details
of the molecule type.
For reactions
We have defined the HFPNe modeling rules for the effect
terms of the reactions in TP. Basically, a reaction in TP is
converted into one or more csml:process elements in
CSML. The participants in a reaction are converted into
pairs of csml:entity and csml:connector elements. The
type attribute of csml:connector indicates the role of an
entity and whether it is involved as an input or an output
in a process. The values are class names defined in CSO
[19]: InputProcess as an input substrate, InputAssociation
as an input activator, InputInhibition as an input inhibi-
tor, and OutputProcess as an output product. The role of
the participating entity is decided from the combination
of the effect terms and the description of the entity in TP.
The OutputProcess type connector may indicate the role
of the process as an input.
The reactions in TP are mainly divided into three types:
pathway step, molecular evidence, and semantic. The first
two types are converted into simulatable processes in
CSML, while semantic level reactions cannot be directly
converted into processes since the details of the reactions
are not given. However, a semantic level reaction may
have the tp:pathway_step and tp:molecular_evidence ele-
ments, which store the related pathway step and evidence
reactions, respectively. In such a case, it is possible to
reconstruct a simulatable model. During conversion,
default values are assigned to simulation related parame-
ters defined in CSML. Otherwise, the semantic reaction is
mapped to the csml:fact element in CSML, which is still
useful for examining the result of the model simulation.
For example, one semantic reaction describes that mole-
cule A is increased after the stimulation of drug B via an
unknown indirect regulation. Because there are no details
of the reaction, the participants of the reaction (A and B)
and any effect terms will be saved into csml:fact. In a sim-
ulation tool such as Cell Illustrator [24,25], the user can
check the correspondence between the simulation results
of the whole pathway and the experimental results
described in csml:fact for the reaction.
The conversion results based on the HFPNe modeling
rules described in Methods section are shown in Figure 4
and Figure 5. Because of the limitation of space, the results
are divided into two figures. We have selected one reac-
tion for each group of rules as an example and provide the
conversion result of the reaction. The left and right col-
umns list the element names and their corresponding val-
ues in TP and CSML, respectively. The last row shows a
drawing by PathwayBuilder [21] for TRANSPATH and that
by Cell Illustrator [24,25] for CSML. PathwayBuilder uses
the following legend for modeling: an oval with a name
for proteins; rectangle with name, genes; small rectangle
with no name, reactions; black line, mass flow; grey line,
activation; red line, inhibition; and blue line, catalysis. In
the Cell Illustrator drawing, the icons of the processes are
also defined in CSO with their corresponding names as
predefined instances. After conversion, the inferred entity
that is necessary for simulation but missing in the original
TP model is represented in italics and emphasized with a
red box in the Cell Illustrator drawing. However, some
effect terms that are assigned to pathway steps or molecu-
lar evidences in the original TP are ambiguous and cannot
be directly used in the CSML simulation model. For exam-
ple, as in Figure 4(b) and Figure 5(b), the effect term that
includes "regulation" cannot clarify the role of a partici-
pant, e.g., whether it activates or inactivates the event.
Therefore, we must add two connectors for the partici-
pant.
For pathways
A pathway is considered as a logical combination of reac-
tions. The tp:pathway element, which consists of reactions
and molecules, is converted into one csml:project element
including one csml:model element. During conversion,
we first consider pathway level reactions. If there are no
pathway level reactions, evidence level reactions are con-
sidered. In addition, reactions related to a specific mole-
cule as upstream and downstream are also used to build a
pathway in CSML. As an example, we selected a pathway
that fMLP activates ERK1 via the predominant MEK iso-
form in human neutrophils, MEK2 in TP. The pathway
consists of two reactions XN000015421; fMLP ---> MEK2
(activation; phosphorylation) and XN000000703; MEK2
---> ERK1 (activation; phosphorylation). Figure 6 shows
(a) the PathwayBuilder view from TRASPATH, (b) Cell
Illustrator view after conversion, (c) and (d) simulation
results with default and adjusted parameters, respectively.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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Graphics automatically generated for Cdc25 family proteins defined in TP Figure 2
Graphics automatically generated for Cdc25 family proteins defined in TP.
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Discussion
We are developing a systematic translation method for
generating dynamic pathway models with visualization in
CSML. We have suggested a formal mechanism that com-
bines Petri nets modeling and the semantics in each bio-
logical reaction. The modeling rules generate a
simulatable model for the whole pathway as a combina-
tion of processes as well as for an individual process. Our
modeling rules can be applied to semi-structured infor-
mation stored in TP.
When translating data, we have first observed that TP has
an inconsistent and incomplete representation. In TP, the
roles of the molecules in tp:reactants and tp:produces are
changed along with the effect terms described in the
tp:effect element. This inconsistency occurs because the
effect terms reflect the descriptions in the literature. The
relationship between tp:reactants and tp:produces is sim-
ilar to that between a subject and an object in English
grammar. Therefore, it does not reflect the biological rela-
tionship in a reaction. For example, from the sentence "A
activates the binding of B," A is defined as a reactant and
not an enzyme. This kind of description makes consistent
interpretation impossible.
Secondly, TP is a database for static pathway models and
generates a static drawing with a high level of abstraction,
which is useful in providing a broad overview of path-
ways; moreover, this representation style is familiar to
biologists. However, it increases the effort required to
extract the essential information to generate a simulatable
model. The implicit representation is shown as follows:
￿ The modification information for the molecule is mixed
together in the name of the molecule in tp:molecule.
￿ The locations where the reaction has been shown indi-
cate places including the cell line, stage, organ, and species
used in the original literature, which are described all in
tp:locations in tp:reaction. CSML separately describes the
tissue type, cell type, and organism (species) as biological
properties.
￿ Cellular compartment for the molecule and reaction is
important to locate them at biologically meaningful loca-
tions in a cell. For example, the effect term "translocation"
indicates a regulated transfer of a signaling molecule from
one location to another location. It will improve the
understanding of the pathway if the cellular compart-
ments are described. However, TP does not explicitly
define this information.
To improve the exchange and integration capabilities with
the successive releases of TRANSPATH, we suggest that
TRANSPATH uses a common vocabulary to annotate data
such as tp:effect. Mature core terms defined in CSO for
The converted results showing the difference between molecule types Figure 3
The converted results showing the difference between molecule types. (a) a basic type rictor(h) is shown as hexagon 
(b) an isogroup type rictor(h) is shown as pentagon.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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Conversion results of reactions in TP Figure 4
Conversion results of reactions in TP. (a) Rule 1: TP reaction (XN000000299) PLA2 + NTP --ERK {p}--> PLA2{p} + NDP 
(b) Rule 2: TP reaction (XN000038035) 14-3-3sigma(m.s.) --> Bax(m.s.) (c) Rule 3: TP reaction (XN000077011) PABPC1(m.s.) 
--> eIF-4AI(m.s.) (d) Rule 4: TP reaction (XN000005775) C/EBPbeta(LAP)(r) --> c-fos(h).
 TP  CSML 
(a) effect  	
 process  	


reactants  



entity with 
connector 
	

	

produces  



		

	

enzyme  
  !		

 
(b) effect  	



		


process  



reactants   !"#"#$	
%$&&' entity with 
connector 
"#$%$%&'
('))*+	

,
	+
produces  (	)%$&&'
 -
.('))*	

-
.('))*	

 
(c) effect  	
*	
+
,- process  -,&
reactants  (. %$&&'
 entity with 
connector 
-/"('))*	

produces  /0"!/%$&&'
 0$#('))*	

 
 
(d) effect  
,-+


		
*	


process  -,&(	"*
,


	(	*
reactants  .1(,
	%'%' entity with 
connector 
/1-+
(*(
*	
	"
produces  "%'
 $2(*	
2
'	
/1-+
(*(
*3	
2
'	"

,	
	
 BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
Page 9 of 17
(page number not for citation purposes)
Conversion results of reactions in TP (continued) Figure 5
Conversion results of reactions in TP (continued). (a) Rule 5: TP reaction (XN000005273) BAG-1(h) --> ER(h) (b) Rule 
6: TP reaction (XN000038115) 5-ht-5AR(m.s.) --> oxytocin(m.s.) (c) Rule 7: TP reaction (XN000114099) cel-let-7 --/ daf-
12(ce).
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Conversion results and simulation based on CH000000006, a pathway in TP Figure 6
Conversion results and simulation based on CH000000006, a pathway in TP. (a) PathwayBuilder view from TRANS-
PATH. (b) Cell Illustrator view after conversion: The pathway is loaded into CI and drawn by default layout algorithm. (c) Sim-
ulation results with assigned parameters during conversion in Cell Illustrator. The chart shows the changes of molecule 
concentration along with those of time. The y-axis shows relative molecules' concentrations without units. The x-axis shows 
the changes of time. The needed values are automatically assigned during conversion for basic usage. (d) Simulation results with 
adjusted parameters in Cell Illustrator. The same notations are used as (c). The user can adjust the values during investigation 
and the results such as the changes of concentration with time will be saved into CSML. Note that this chart does not corre-
spond to the experimental results.
(a) 
 
(b) 
 
(c) 
 
(d) BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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biological properties such as biological events and cellular
locations will be useful because CSO includes most of the
external references referred in BioPAX [18] for controlled
vocabularies and reorganizes them for system dynamics.
In this work, we implemented rules for the automatic gen-
eration of icons for molecules, reflecting the species, mod-
ification, and subsumption relationship in the hierarchy
of the molecules. The visualization could be improved by
using a description in TP as follows:
￿ The similarity between proteins, and between an miRNA
and its precusor pre-miRNA can be indicated by using
similar line patterns. It could be supported by tp:klass, the
classification stretches over all molecules, and tp:go, the
GO terms from molecular functions and biological proc-
esses.
￿ The stroke widths of connectors reflect the quality of the
experimental results in the primary literature, ranging
from 1 to 5 in tp:quality (highest to lowest reliability with
regard to biological relevance).
Conclusion
We used a systematic method to reconstruct dynamic sig-
naling pathways from static pathway databases. We iden-
tified a set of rules for HFPNe modeling in terms of
biological processes. The basic methodology for these
rules can be applied to other similar databases to build
dynamic pathways. The conversion results are saved in
CSML and can be used for further biological investigation,
e.g., conversion to other formats for use with different vis-
ualizing tools and different simulating tools. The pro-
posed methods were applied to the TRANSPATH
professional 8.1. During our research, TRANSPATH 8.4 is
released with more data, but with no changes of the for-
mat. The converted results in CSML are available for both
professional (TRANSPATH 8.4) and academic (TRANS-
PATH 7.4) users via the Cell Illustrator Online (CIO) [28].
TRANSPATH 7.4 in CSML is free to all academic users
upon registration. It is possible to search which entities
(including genes and proteins modified/complex) are
related to a queried entity and which processes include the
queried entity. The part of or all results can be used to
build a pathway. Each pathway stored in TRANSPATH is
provided as one project in CIO.
Methods
All the signaling pathways in TP are modeled as bipartite
graphs with molecules and reactions as two disjoint node
sets. Each molecule is linked to the reaction in which it
participates. Both molecules and reactions are hierarchi-
cally organized [20].
TP mainly consists of four components: pathway, reac-
tion, molecule, and gene. The pathway component stores
a group of chains and pathways, which consist of a set of
reactions. The reaction component stores the cellular
processes of the molecule and gene components, e.g., p53
binds to Mdm2. The molecule component describes the
protein and small molecule information, e.g., p53 protein
and Mdm2 protein. The gene component stores the gene
information, e.g., p53 gene and MDM2 gene.
Visualization method for molecules in TRANSPATH
In TP, molecules that are gene products are separated from
genes. Molecules are basically divided into proteins and
nonproteins as shown in Table 2. The proteins are further
divided into 16 types depending on whether the molecule
is species-specific or not, modified or not, and complex or
not. The noncomplex proteins in rows 4–6 in Table 2 are
categorized into three types: basic, isogroup, and family.
"Basic" represents an individual polypeptide having a
sequence and a molecular weight, e.g., the proteins
Cdc25B1 and Cdc25B2 in humans. All the products from
one gene are grouped into an "isogroup," e.g., the Cdc25A
and Cdc25B protein groups in humans. The "family" is a
more general "isogroup", e.g., the Cdc25 proteins in
humans. There exists a molecular hierarchy among fami-
lies, isogroups, and basics in decreasing order of granular-
ity. The prefix "ortho" is attached for species-nonspecific
molecules. The suffix "_mod" is added to represent a
chemical modification such as phosphorylation. The
complex type has "complex" in its name.
The molecule type is stored in the tp:type element. The
relationships between molecules are described in
tp:members for any subfamily and in tp:groups for any
superfamily of a molecule. For example, PDGF (ortho-
family) has PDGF A (orthogroup) as a member and
belongs to the PDGF/VEGF family (orthofamily) super-
family. In the case of a species-specific protein, Ret(h)
(isogroup) has Ret-1(h) and Ret-2(h) (basic) as its mem-
bers and belongs to the Ret (orthofamily) and Src(h)
(family) superfamilies. If the molecule is a complex, the
components of the complex are described in tp:stateofs.
Unfortunately, the post-translational modification (PTM)
of a molecule is not explicitly defined in TP, but is,
instead, described by a human-readable identifier in
tp:name. Detailed information regarding PTMs is repre-
sented with braces, e.g., {p} for phosphorylation at an
unknown position and {pT387} for phosphorylated thre-
onine at position 387. The name of a complex uses a
colon, e.g., A:B. In addition, the species information is
also included in tp:name by using parentheses, e.g., (h)
for Homo sapiens and (m) for Mus musculus, although there
is the tp:species element for describing species.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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The molecular hierarchy would be useful for pathway vis-
ualization, providing a qualitative understanding of the
information content. In this work, we focused on devel-
oping a method to graphically represent such information
in a manner that users can understand without extracting
the details of the tp:molecule structure as much as possi-
ble. We choose three features to be represented: the sub-
sumption relationship among noncomplex proteins,
species, and modification. For visualization of molecules
based on the types shown in Table 2, molecules are
depicted as icons with different visual properties: the
number of line segments, line patterns, and colors.
Modeling rules for reactions in TRANSPATH
In TRANSPATH, a reaction describes any kind of interac-
tion between signaling entities (molecules or genes) in
signaling or regulatory events. A reaction is the basic
building block of the pathway.
There are four kinds of reactions in TP: molecular evi-
dence, pathway step, decomposition, and semantic [29].
The "molecular evidence" reactions are extracted from sci-
entific publications by manual curation reflecting the
results of experiments. Because the same reaction may be
dealt with using different experimental setups, these reac-
tions contain some redundancy and hetero-species data.
Such reactions are condensed into nonredundant path-
ways and summarized into one reaction step; this is called
the "pathway step" reaction as a more general level. The
"semantic level" reaction is the most abstract reaction,
providing a broader shortcut overview of the signal trans-
duction pathways without biochemical details. For exam-
ple, a DNA binding reaction can be represented as
"COUP-TF2(h) --> CRBPII(m)" (id XN000007077) on
the "molecular evidence" level and "COUP-TF2 (NR2F2)
--> CRBPII" (id XN000059803) on the "semantic" level.
As a result, in the hierarchy of reactions, a "semantic level"
reaction may consist of multiple "pathway step" reactions,
and each "pathway step" reaction, in turn, consists of mul-
tiple "molecular evidence" reactions. The "decomposi-
tion" reaction explains the mechanism of a reaction and
identifies the reacting molecules of reactions that occur in
complexes.
The main features of a reaction are the explanation of a
detailed biochemical reaction and the molecules involved
in the reaction such as tp:effect and tp:reactants.
The tp:effect element provides the details of reaction
mechanisms such as phosphorylation and cleavage; TP
defines 149 single effects. A reaction may be annotated by
more than one effect term. However, combinations of
effect terms, e.g., "binding; phosphorylation," have no
explicit definitions. Furthermore, the difference between
"binding; phosphorylation" and "phosphorylation; bind-
ing" is unclear. Thus, we disregard the order of terms
described in tp:effect. As a result, the above two terms are
considered equivalent. There are, in total, 521 different
effect terms used to explain reactions in TP. In this work,
we consider the 50 most frequently used effects for con-
version, which occupy over 97% of all reactions, as shown
in Table 3; the other effect terms are rarely used in TP. The
remnant effect terms are mapped to unknown processes
in CSML, though they will be converted with a similar
methodology described in this section.
In CSML, a process is a biological event that affects the
kinetics of a simulation. In addition, a process defines an
elementary reaction, and not a combination of reactions.
CSML refers to 274 biological events defined in CSO to
annotate the type attribute of csml:process. Biological
events in CSO are classified into cellular, organism,
molecular, and physiological events. In this work, the
CSO terms defined for molecular events are used to
describe the reactions in TP.
There are several difficulties encountered when develop-
ing modeling rules for mapping between tp:effect and the
Table 2: Types of molecules defined in TP.
(a) Proteins
species-specific species-nonspecific
nonmodified modified nonmodified modified
Complex complex_mod orthocomplex orthocomplex_mod
Family family_mod orthofamily orthofamily_mod
Isogroup isogroup_mod orthogroup orthogroup_mod
Basic basic_mod orthobasic orthobasic_mod
(b) Nonproteins
group (XOR), mRNA basic, miRNA basic, pre-miRNA basic, small molecule, and otherBMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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type attribute of csml:process. First, tp:effect uses terms to
place more importance on the results of a reaction than
on the reaction itself. Generally, the results of a reaction
and the reaction itself are not easily distinguishable. For
example, a "decrease of secretion" could arise from the
existence of another protein or as a consequence of arbi-
trary reactions such as the inhibition of intracellular pro-
tein hydrolysis. Thus, terms such as "increase of secretion"
and "decrease of amount" are intended to represent the
dynamic behaviors in TP. In CSML, such effects are han-
dled by connectors (OutputProcess in CSO) that link a
process to an output entity, which hold the detailed role
of the process. Secondly, one effect term in TP may imply
several steps of molecular events in CSO. For example,
"expression" is defined as a transfer of the information
encoded in DNA into a protein; reactions with effect
expression include several steps: transcription, splicing,
capping, and translation in TP. In CSO, expression is rep-
resented as two processes: DNA-mRNA transcription and
mRNA-protein translation. Thirdly, on the other hand,
serialized effect terms in TP may mean one step of a
molecular event in CSO. For example, the effect term
"phosphorylation; automodification" in TP is mapped to
autophosphorylation in CSO. Thus, a direct mapping of
an effect term in TP to a molecular event in CSO is not
available.
Molecules involved in a reaction are described in tp:reac-
tants, tp:produces, tp:enzyme, and tp:inhibitor, whose
names indicate the roles of the molecules. However, the
description in TP is not consistent in the sense that the
role of each participant is altered depending on the reac-
tion. For example, the reaction (XN000004663) "NO --/
Caspase-1(h)" means that NO semantically inhibits an
unknown activity of Caspase-1. In this reaction, Caspase-
1 is a reactant and NO is an inhibitor, rather than a prod-
uct and a reactant defined in TP, respectively.
For conversion, we must carefully define the roles of par-
ticipants depending on the effect terms. In addition,
whether the role of an enzyme in a reaction is that of an
activator or an inhibitor is not explicitly described in TP.
If it is difficult to identify the roles of enzymes, we add two
connectors: an association connector (as an activator) and
an inhibitor connector (as an inhibitor) between the
enzyme and the reaction. By default, the inhibition con-
nector will work when the threshold of the connector is
less than the concentration of the enzyme. As to which
one correctly corresponds to experimental results – that
Table 3: The top 50 effect terms of reactions with "pathway step" and "molecular interaction" type in the TRANSPATH database.
No. Effect Rule #(%) No. Effect Rule #(%)
1 binding 1-1 28411 (29.5%) 26 sumoylation 1-1 89486 (92.8%)
2 expression 5-1 53378 (55.4%) 27 decrease of phosphorylation 3-1 89846 (93.2%)
3 DNA binding 4-1 59299 (61.5%) 28 dephosphorylation 1-1 90183 (93.5%)
4 phosphorylation 1-1 64800 (67.2%) 29 increase of binding 2-1 90516 (93.9%)
5 activation 2-1 68829 (71.4%) 30 predicted 7 90844 (94.2%)
6 increase of abundance 2-1 72516 (75.2%) 31 binding; phosphorylation 1–2 91130 (94.5%)
7 DNA binding; transactivation 4-1 75753 (78.6%) 32 translocation 1-1 91397 (94.8%)
8 decrease of abundance 3-1 77255 (80.1%) 33 acetylation 1-1 91629 (95%)
9 increase of phosphorylation 2-1 78570 (81.5%) 34 binding; oligomerization 1–2 91853 (95.3%)
10 regulation of abundance 6-2 79728 (82.7%) 35 transrepression 2–3 92052 (95.5%)
11 inhibition 3–4 80790 (83.8%) 36 regulation of phosphorylation 2–4 92247 (95.7%)
12 regulation of activity 6-1 81810 (84.9%) 37 decrease of secretion 3-1 92425 (95.9%)
13 regulation of localization 2–4 82806 (85.9%) 38 activation; binding 3-2 92585 (96%)
14 transactivation 2-1 83507 (86.6%) 39 automodification; phosphorylation 1-1 92734 (96.2%)
15 DNA binding; transregulation 4-3 84120 (87.3%) 40 degradation 1-1 92866 (96.3%)
16 increase of secretion 2-1 84721 (87.9%) 41 exchange 1-1 92995 (96.5%)
17 regulation of protein activity 6-1 85280 (88.5%) 42 oligomerization 1-1 93114 (96.6%)
18 DNA binding; transrepression 4-2 85814 (89%) 43 decrease of protein stability 3-3 93226 (96.7%)
19 cleavage 1-1 86327 (89.5%) 44 hydrolysis 1-1 93327 (96.8%)
20 activation; increase of phosphorylation 2-2 86836 (90.1%) 45 dissociation; phosphorylation 1–3 93420 (96.9%)
21 activation; expression 5-2 87309 (90.6%) 46 degradation; destabilization 3-3 93510 (97%)
22 ubiquitination 1-1 87766 (91%) 47 regulation of secretion 6-2 93593 (97.1%)
23 binding; regulation of localization 1–2 88216 (91.5%) 48 activation; increase of abundance 2-2 93673 (97.2%)
24 processing 1-1 88665 (92%) 49 increase of processing 2-1 93753 (97.3%)
25 binding; regulation of protein activity 1–2 89094 (92.4%) 50 decrease of binding 3-1 93832 (97.3%)
These 50 terms are used to annotate the effects of reactions (pathway step and molecular evidence type), and occupy 97.3% of the total number of 
reactions (96404). The No. column lists the frequency order of the effect terms; the Effect terms; the Rule number in Figure 7; and the #(%) 
column, the accumulated frequency and its percentage in parentheses.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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will be examined via simulation. The speed of one con-
nector is set to zero while another one works.
For a kinetic reaction, the stoichiometric coefficients are
also not explicitly represented in TP, but tp:name of a
reaction contains these values. For example, the reaction
(XN000000000) is described as "2ErbB1 + EGF -->
EGF(ErbB1)2" in tp:name. In this case, we extract the coef-
ficients from tp:name.
There are also elements to indicate the directionality and
reversibility of a reaction. The tp:direct element notifies
whether the reaction is direct or not. If interactions may
contain yet unidentified steps between the reactants and
products at the semantic level, these are indirect interac-
tions. The tp:reversible element is used to denote whether
a reaction is reversible or not. During simulation, the
speed in both directions may be different. Therefore, a
reversible reaction is mapped to two different processes in
CSML.
For implementation, we proposed modeling rules for rep-
resenting the semantics of reactions in terms of HFPNe
modeling. Inference requires an overall interpretation
from the definition of the effect term and the molecule
types described in tp:reactants and tp:produces.
Figure 7 shows the modeling rules for mapping from 50
TP effect terms to CSO molecular events. The columns
show the rule number, the effect terms used in TP, the cor-
responding molecular event in CSO, and the HFPNe dia-
gram. In the third column, the molecular event is prefixed
with "ME_" and the role of the process with "MR_." In the
HFPNe diagram, a circle indicates a participant involved
in a process: i for tp:reactants, o for tp:produces, and e for
tp:enzyme in TP. As shown in the diagram, the roles of the
participants are not consistent but are changed depending
on the effect term. A rectangle represents a process. The
inferred entities are shown in colored circles. If a process
has a specific role, the output connector is represented
with a colored circle, e.g., R1-2 and R1-3. The 16 modeling
rules are grouped together based on the HFPNe diagram.
For example, R1 means a group consisting of rules R1-1,
R1-2, and R1-3. We use this notation hereinafter.
The R1 group shows a reaction catalyzed by an enzyme.
The molecules in tp:reactants and tp:produces are mapped
to input and output entities in CSML. If tp:enzyme is
defined, the enzyme is connected to a process via associa-
tion connectors. R1-2 and R1-3 are basically mapped to
the same HFPNe model, but differ in terms of the molec-
ular event and its role. All effect terms in R1-2 are mapped
to the same event "ME_binding," but each process has a
different role with the "MR_" prefix. For example, "bind-
ing; regulation of localization" is mapped to the event
"ME_Binding," whose role is
"MR_Regulation_of_Localization."
The R2 and R3 groups are basically the same HFPNe
model as R1. However, depending on the effect terms in
TP, the participants play different roles. Furthermore, in
order to generate dynamic pathway models, some partici-
pants may have to be inferred during conversion.
In R2, the molecules in tp:reactants and tp:produces are
mapped to enzymes and output entities in CSML, respec-
tively. For example, the effect term in the reaction
(XN000027773) "SHP-2(h) --> STAT5A(h){pY694}" is
"increase of phosphorylation." This type of reaction in TP
usually omits the input of the reactions. In the above
example, STAT5A(h){pY694} is a phosphorylated mole-
cule, and there is no pre-phosphorylated one before the
process. If there is an explicit need for input entities, they
are inferred. As described before, there is no explicit nota-
tion for the role of an enzyme, i.e., as an activator or an
inhibitor. Basically, the role of an enzyme is assumed to
be that of an activator. If the effect term contains "repres-
sion" or "inhibition," then the role of enzyme is that of an
inhibitor. In R2-3, transrepression is an inhibited reaction
meaning the repression of a gene by a transcription factor
in TP. If the effect term "regulation" is used, we assumed
that the enzyme plays two roles – both that of an activator
and an inhibitor. In R2-4, both association and inhibition
connectors are used to link the enzyme and process.
R3 is different from R2 in the sense that the molecules in
tp:produces are mapped to input entities and not to out-
put entities. In R3-1, the effect term in the reaction
(XN000038092) "5-HT-2B(m.s.) --> Bax(m.s.)" is
"decrease of abundance," i.e., the amount of Bax is
decreased by 5-HT-2B. The effect term "activation; bind-
ing" is interpreted as that the binding activity of tp:pro-
duces is enhanced by tp:reactants. R3-2 is for the effect
term "inhibition." Because the kind of process that is
inhibited is not explicitly stated in TP, this reaction is
mapped to an unknown process.
The effect terms in the R4 group are all related to DNA
binding whose definition is "binding of a protein to the
promoter/enhancer of a gene" in TP. In the description of
the reaction (XN000005775) "C/EBPbeta(LAP)(r) --> c-
fos(h)," tp:reactants is a protein and tp:produces is a gene.
This means that the product of the DNA binding of a pro-
tein activates the transcription of a gene. From the defini-
tion of DNA binding in TP, this reaction implies two
processes: DNA binding and then transcription. In HFPNe
modeling, the complex of DNA and a protein (in tp:reac-
tants) is introduced as a regulator of transcription. The
regulation is identified with the last effect term such as
transactivation and transrepression.BMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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The HFPNe modeling rules to convert from TP reactions to CSML processes Figure 7
The HFPNe modeling rules to convert from TP reactions to CSML processes. The columns show the rule number, 
the effect terms used in TP, the corresponding molecular event in CSO, and the HFPNe diagram. In the third column, the 
molecular event is prefixed with "ME_" and the role of the process is with "MR_." In the HFPNe diagram, a circle indicates one 
or more participants involved in a process: i for tp:reactants, o for tp:produces, and e for tp:enzyme in TP. A rectangle 
describes a process. The inferred entities for the corresponding process are shown in colored circles. If a process has a specific 
role, the output connector is shown with a colored circle.
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binding phosphorylation cleavage
ubiquitination processing
sumoylation dephosphorylation
acetylation degradation exchange
oligomerization hydrolysis
translocation
automodification; phosphorylation
ME_Binding ME_Phosphorylation ME_Cleavaeg
ME_Ubiquitination ME_Processing
ME_Sumoylation ME_Dephosphorylation
ME_Acetylation ME_Degradation ME_Exchange
ME_Dimerization ME_Hydrolysis
ME_Translocation
ME_AutoPhosphorylation
binding; regulation of localization
binding; regulation of protein activity
binding; phosphorylation
binding; oligomerization
ME_Binding with role
MR_Regulation_of_Localization
MR_Regulation_of_Protein_Activity
MR_Phosphorylation
MR_Dimerization
dissociation; phosphorylation ME_Dissociation with role MR_Phosphorylation
decrease of secretion
activation; binding
decrease of protein stability
degradation; destabilization
ME_UnknownProcess
ME_UnknownProcess
ME_Binding
ME_ProteasomeDegradation
ME_ProteasomeDegradation
decrease of abundance
inhibition ME_UnknownProcess
DNA binding ME_DnaBinding (p1) and ME_Transcription (p2)
DNA binding; transactivation
DNA binding; transrepression
DNA binding; transregulation
expression ME_Transcription (p1) and ME_Translation (p2)
activation; expression ME_Transcription (p1) and ME_Translation (p2)
regulation of activity ME_UnknownInactivation (p1) and ME_UnknownActivation (p2)
regulation of protein activity
regulation of abundance ME_Un knownProcess (p1) and ME_Un knownProcess (p2)
regulation of secretion
predicted ME_Translation
1-1
1-2
1-3
2-1
2-2
2-3
2-4
3-1
3-2
4-1
4-2
4-3
5-1
5-2
6-1
6-2
7
increase of secretion
increase of phosphorylation
decrease of phosphorylation
increase of processing
ME_UnknownProcess
ME_UnknownProcess
ME_Phosphorylation
ME_Phosphorylation
ME_Processing
increase of abundance
activation
increase of binding
decrease of binding transactivation
ME_UnknownActivation
ME_Binding
ME_Transcription ME_Binding
activation; increase of phosphorylation
activation; increase of abundance
ME_Phosphorylation with role MR_Activation
ME_UnknownProcess with role  MR_Activation
transrepression ME_Transcription
regulation of localization
regulation of phosphorylation
ME_Translocation
ME_PhosphorylationBMC Systems Biology 2008, 2:53 http://www.biomedcentral.com/1752-0509/2/53
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The R5 group is for gene expression and is defined as
"transfer of information encoded in the DNA into the pro-
tein" in TP. For HFPNe modeling, two molecular events,
transcription (p1) and translation (p2), are used to repre-
sent expression. The difference between R5-1 and R5-2 is
in the role of tp:reactants because of the effect term "acti-
vation" in R5-2. In R5-1, tp:reactants is mapped to a prod-
uct generated by a transcriptional process (p1). On the
other hand, in R5-2, tp:reactants is an activator that
enhances the transcriptional process. In this case, the
product of transcription (p1) must be inferred.
The R6 group is for effect terms combining abundance/
activity and regulation. These terms can be used to repre-
sent a circumstance in which the target protein abun-
dances are increased/decreased by antibodies, e.g.,
antibodies interacting directly with protein active sites or
blocking the access of substrates to the active sites. For
these terms, we use two HFPNe models. In R6-1, the
enzyme regulates the activity of the product as the activa-
tor of two processes – unknown inactivation (p1) and
unknown activation (p2) – in which the product takes
part. On the other hand, in R6-2, the enzyme regulates
two unknown processes via two connectors. R6 is differ-
ent from R2 in the sense that the terms in R2-1 describe an
activator of a process, including the unknown process,
and the terms in R2-4 describe a regulator for a specific
process such as localization. The detailed mechanism is
usually described in tp:comment. The contents of tp:com-
ment may be useful for building a better model.
Rule 7 is a specific type for the effect term "predicted,"
whose definition is "in silico predicted interactions of an
miRNA with the complementary site of a target mRNA."
This term indicates that miRNAs repress the translation of
target mRNAs. For HFPNe modeling, the reactant
(miRNA) inhibits the translational process of the product
(mRNA) and the input entity (pre-translational mRNA)
must be inferred.
Conversion of Pathways
The tp:pathway element describes a pathway and may
contain any number of chains as pathway components.
The chains are sets of consequent reactions that are path-
way steps. The chains are classified into three types: chain,
evidence chain, and metabolic chain. When a sequence of
reactions has been reported by one primary paper, the
chain is labeled as an "evidence chain." The "metabolic
chain" means that the chains are constructed from meta-
bolic pathway step reactions. Each type of chain is also
defined as a pathway in TP. We call pathways that consist
of chains as normal pathways to differentiate them from
the three chain-type pathways.
In TP, there are 1221 pathways in total. The number of
each pathway type is 119, 589, 356, and 159, in the order
of normal pathway, chain, evidence chain, and metabolic
chain. The tp:pathway element may contain tp:chains
when it is a normal pathway to describe the chains. In the
tp:pathway element, the tp:reactions_involved and
tp:molecules_involved elements specify the reactions and
molecules involved in the pathways, respectively.
Each pathway in TP is mapped to one CSML file which
contains one csml:project that has one csml:model.
Because tp:chains has a certain meaning for a group of
reactions, tp:pathway and tp:chains are mapped to
csml:fact, which means a nonsimulatable biological fact.
The involved reactions and molecules are mapped to the
respective components of csml:processSet and csml:entit-
ySet. Each reaction involved in the tp:pathway will be
mapped to one HFPNe modeling rule depending on its
effect terms, as described in the previous section.
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